The NACE Clinical Highlights Show

NACE
  • 4.6 (22)
  • MEDICINE
  • UPDATED BIMONTHLY

Engage with expert NACE faculty for discussions about current clinical strategies for common and rare health conditions that you can use in clinical practice immediately, and that work for you and your patients.

  1. FEB 1

    NACE Journal Club #27

    The NACE Journal Club with Dr. Neil Skolnik, provides review and analysis of recently published journal articles important to the practice of primary care medicine. In this episode Dr. Skolnik and guests review the following publications: 1. USDA Dietary Guidelines 2025-2030. Discussion by:  Guest: Phillip Leiberman, MD Resident Family Medicine Residency Program  Jefferson Health - Abington 2. The Effect of Substituting Wate for Artificially Sweetened Beverages on Glycemic and Weight Measures in People With Type 2 Diabetes: The Study of Drinks With Artificial Sweeteners (SODAS), a Randomized Trial – Diabetes Care 2025. Discussion by:  Guest: Neil Skolnik, MD Professor of Family and Community Medicine Sidney  Kimmel  Medical College Thomas Jefferson University Associate Director - Family Medicine Residency Program Jefferson Health – Abington 3. Caffeinated Coffee Consumption or Abstinence to Reduce Atrial Fibrillation The DECAF Randomized Clinical Trial – JAMA 2025. Discussion by:  Guest: Neil Skolnik, MD Professor of Family and Community Medicine Sidney  Kimmel  Medical College Thomas Jefferson University Associate Director - Family Medicine Residency Program Jefferson Health – Abington 4. Exercise for the Treatment of Depression. Cochrane Database of Systematic Reviews 2026 Discussion by: Guest: Aaron Sutton - Behavioral Specialist  Family Medicine Residency Program Chief Wellness Officer for Graduate Medical Education  Jefferson Health – Abington Medical Director and Host, Neil Skolnik, MD, is an academic family physician who sees patients and teaches residents and medical students as professor of Family and Community Medicine at the Sidney Kimmel Medical College, Thomas Jefferson University and Associate Director, Family Medicine Residency Program at Abington Jefferson Health in Pennsylvania. Dr. Skolnik graduated from Emory University School of Medicine in Atlanta, Georgia, and did his residency training at Thomas Jefferson University Hospital in Philadelphia, PA.  This Podcast Episode does not offer CME/CE Credit.  Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

    36 min
  2. APAPP From Idea to Abstract

    JAN 1

    APAPP From Idea to Abstract

    Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

    31 min
  3. APAPP Welcome to the ICU

    JAN 1

    APAPP Welcome to the ICU

    Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

    56 min

  4. JAN 1

    NACE Journal Club #26

    The NACE Journal Club with Dr. Neil Skolnik, provides review and analysis of recently published journal articles important to the practice of primary care medicine. In this episode Dr. Skolnik and guests review the following publications: 1. Candesartan for Migraine Prophylaxies. The Lancet 2025 . Discussion by: Guest: Max Schidt, MD Resident - Family Medicine Residency Program Jefferson Health - Abington 2. One vs two dose HPV vaccination for prevention of HPV infection – The New England Journal of Medicine 2025. Discussion by: Guest: Neil Skolnik, MD Professor of Family and Community Medicine Sidney  Kimmel  Medical College Thomas Jefferson University Associate Director - Family Medicine Residency Program Jefferson Health – Abington 3. The Surpass CVOT trial for prevention of MACE in people with Diabetes – The New England Journal of Medicine 2025. Discussion by: Guest: Neil Skolnik, MD Professor of Family and Community Medicine Sidney  Kimmel  Medical College Thomas Jefferson University Associate Director - Family Medicine Residency Program Jefferson Health – Abington 4. The New American Cancer Society Guidelines for Screening for cervical cancer – that includes self swab for HPV. Discussion by: Guest: Amy Clouse, MD  Associate Director - Family Medicine Residency Program  Jefferson Health – Abington Medical Director and Host, Neil Skolnik, MD, is an academic family physician who sees patients and teaches residents and medical students as professor of Family and Community Medicine at the Sidney Kimmel Medical College, Thomas Jefferson University and Associate Director, Family Medicine Residency Program at Abington Jefferson Health in Pennsylvania. Dr. Skolnik graduated from Emory University School of Medicine in Atlanta, Georgia, and did his residency training at Thomas Jefferson University Hospital in Philadelphia, PA.  This Podcast Episode does not offer CME/CE Credit.  Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

    25 min

  5. 12/12/2025

    CME/CE Podcast: Responding to the Science – Biologics in Practice in COPD

    For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit: https://www.mycme.com/courses/responding-to-the-science-biologics-in-practice-in-copd-10511 Summary This enduring podcast activity provides pulmonologists and clinicians managing COPD with timely updates on the evolving role of biologics management. Featuring expert discussions, the program explores recent GOLD guideline revisions, the integration of new and emerging biologic therapies, and evidence-based decision-making based on clinical trial data and real-world practice. Covering guidelines, clinical trials, and clinical scenario, this activity emphasizes the translation of complex data into practical strategies. Learners will gain improved knowledge and competence related to patient selection, eosinophil thresholds, and clinical decision making. This podcast was recorded and is being used with permission of the presenters. Learning Objectives Discuss recent evidence surrounding the use of biologic agents in the management of patients with COPD, including patient populations and outcomesIntegrate the use of biologic agents into the management of patients with COPD based on guidelines and clinical evidence for new and emerging agentsThis activity is accredited for CME/CE Credit The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The National Association for Continuing Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. The National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.25 contact hours (which includes 0.25 hours of pharmacology). For additional information about the accreditation of this program, please contact NACE at info@naceonline.com. Summary of Individual Disclosures Please review faculty and planner disclosures here.  Disclosure of Commercial Support This educational activity is supported by an independent medical education grant from GSK and an independent educational grant from Regeneron Pharmaceuticals, Inc and Sanofi. Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

    16 min

  6. 12/09/2025

    CME/CE Podcast: Harnessing the Night to Win the Day in ADHD

    For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit: https://www.mycme.com/courses/adhd-sleep-and-symptom-control-10355 Summary Early-morning symptom control remains a critical gap in ADHD management, often contributing to family stress and impaired daily functioning. In this podcast/webcast activity, Dr. Joel Young and Jo Hughes, DMSc, PA-C, CAQ-PSY, explore the limitations of traditional ADHD medications in achieving full-day coverage and discuss available strategies to improve early-morning outcomes. Learners will gain practical insights into the clinical use of nighttime-dosed medications, including an innovative delayed-release/extended-release stimulant, and understand the pharmacologic characteristics that contribute to its efficacy in providing sustained symptom control. This podcast was recorded and is being used with permission of the presenters. Learning Objective Examine the ADHD treatment options that use nighttime dosing to achieve full-day symptom controlThis activity is accredited for CME/CE Credit This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the ACCME to provide continuing medical education for physicians. The National Association for Continuing Education designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider number 121222. This activity is approved for 0.50 contact hours (which includes 0.50 hours of pharmacology). For additional information about the accreditation of this program, please contact NACE at info@naceonline.com. Summary of Individual Disclosures Please review faculty and planner disclosures here. Disclosure of Commercial Support This educational activity is supported by an educational grant from Collegium Pharmaceutical, Inc. Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

    25 min

  7. 12/09/2025

    CME/CE Podcast: Personalized Antidepressant Choices for Better Outcomes

    For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit: https://www.mycme.com/courses/personalized-antidepressant-choices-for-better-outcomes-in-mdd-10266 Summary Emphasizing a measurement-based, patient-centered model, this is an enduring podcast/webcast designed for psychiatrists who seek to refine their approach to managing major depressive disorder (MDD). Despite an expanding array of pharmacologic options, many patients continue to experience side effects and residual symptoms that undermine adherence and long-term recovery. Led by Drs. Gregory Mattingly and Gerald Maguire, this activity equips clinicians with evidence-based strategies to compare the nuanced risk–benefit profiles of antidepressants and apply them to individualized treatment plans. This podcast was recorded and is being used with permission of the presenters. Learning Objectives Assess the risk–benefit profiles of available antidepressants, including their impact on residual symptoms, to optimize treatment decisions for patients with MDDImplement personalized, measurement-based treatment strategies for patients with MDD to address residual symptoms, promote adherence, and improve outcomesThis activity is accredited for CME/CE Credit This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the ACCME to provide continuing medical education for physicians. The National Association for Continuing Education designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider number 121222. This activity is approved for 0.75 contact hours (which includes 0.75 hours of pharmacology). For additional information about the accreditation of this program, please contact NACE at info@naceonline.com. Summary of Individual Disclosures Please review faculty and planner disclosures here. Disclosure of Commercial Support This educational activity is supported by an educational grant from Takeda Pharmaceuticals U.S.A., Inc. Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

    33 min

  8. 12/01/2025

    NACE Journal Club #25

    The NACE Journal Club with Dr. Neil Skolnik, provides review and analysis of recently published journal articles important to the practice of primary care medicine. In this episode Dr. Skolnik and guests review the following publications: 1. FDA change in Boxed Warning Label for Hormone Replacement Therapy.  Discussion by: Guest: Anupriya Grover Wenk, DO Faculty - Family Medicine Residency Program Jefferson Health - Abington 2. Evolocumab in Patients without a Previous Myocardial Infarction or Stroke – The New England Journal of Medicine 2025. Discussion by: Guest: Neil Skolnik, MD Professor of Family and Community Medicine Sidney  Kimmel  Medical College Thomas Jefferson University Associate Director - Family Medicine Residency Program Jefferson Health – Abington 3. AI-Powered Lifestyle Intervention vs Human Coaching in the Diabetes Prevention Program – JAMA. Discussion by: Guest: Neil Skolnik, MD Professor of Family and Community Medicine Sidney  Kimmel  Medical College Thomas Jefferson University Associate Director - Family Medicine Residency Program Jefferson Health – Abington 4. Incremental effect of healthy lifestyle habits when taking GLP-1 RA medications on Cardiac Risk Reduction.  Discussion by: Guest: Joe Gonella, MD Resident– Family Medicine Residency Program Jefferson Health – Abington Medical Director and Host, Neil Skolnik, MD, is an academic family physician who sees patients and teaches residents and medical students as professor of Family and Community Medicine at the Sidney Kimmel Medical College, Thomas Jefferson University and Associate Director, Family Medicine Residency Program at Abington Jefferson Health in Pennsylvania. Dr. Skolnik graduated from Emory University School of Medicine in Atlanta, Georgia, and did his residency training at Thomas Jefferson University Hospital in Philadelphia, PA.  This Podcast Episode does not offer CME/CE Credit.  Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

    35 min
See All (129)

Ratings & Reviews

4.6
out of 5
22 Ratings

About

Engage with expert NACE faculty for discussions about current clinical strategies for common and rare health conditions that you can use in clinical practice immediately, and that work for you and your patients.

Information

  • Creator
    NACE
  • Years Active
    2019 - 2026
  • Episodes
    129
  • Rating
    Clean
  • Copyright
    © 2026 National Association for Continuing Education
  • Show Website
    The NACE Clinical Highlights Show